Soonchunhyang Med Sci.
2016 Dec;22(2):98-101. 10.0000/sms.2016.22.2.98.
Adipokines, Superoxide Dismutases and Progression of Symptomatic Intracranial Atherosclerotic Stenosis
- Affiliations
-
- 1Department of Neurology, Dongguk University Ilsan Hospital, Goyang, Korea. totopia@duih.org
- KMID: 2386998
- DOI: http://doi.org/10.0000/sms.2016.22.2.98
Abstract
OBJECTIVE
We aimed to investigate the relationship between adipokines and antioxidation enzyme and the risk of progression of symptomatic intracranial atherosclerotic stenosis (ICAS).
METHODS
Of 409 patients who participated in the TOSS-2 (trial of cilostazol in symptomatic intracranial stenosis-2) study, 52 patients showed progression of symptomatic ICAS on magnetic resonance angiography at seven months after an index stroke. We randomly selected 20 patients with progression and 20 age- and sex-matched control patients. We serially collected blood sample initially, one month, and seven months after an index stroke. Then, multiplex analysis of biomarkers was performed for adiponectin, resistin, leptin, and superoxide dismutase-1, 2, 3.
RESULTS
Demographic features and risk factors such as hypertension, diabetes, and smoking history were comparable between the two groups. Control group showed higher adiponectin levels at 7 months than progression group (P=0.05) and a significant in-creasing trend (P for trend=0.01). Resistin, leptin, and superoxide dismutase-1, 2, 3 levels were not different between the progression and control group initially, one month, and seven months after an index stroke.
CONCLUSION
Increase of adiponectin level showed protective effect in the progression of ICAS. Resistin, leptin, and superoxide dismutase-1, 2, 3 levels are not different between the groups. Further large numbers of patients with longer follow-up studies are needed.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Guideline for Intracranial Stenting of Symptomatic Intracranial Artery Stenosis: Preliminary Report
- Platelet-Derived Growth Factor Is Associated with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
- Intracranial Atherosclerosis: Incidence, Diagnosis and Treatment
- Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
- Wingspan Stenting for Symptomatic Severe In-Stent Stenosis of a Closed-Cell Stent after Stent-Assisted Coiling of a Ruptured Intracranial Aneurysm
